firewatcher Posted October 17, 2018 Report Share Posted October 17, 2018 Hot off the presses. I'm not sure how this will impact our treatment in the future, but I am sure it will. "She suggests the body may avoid putting energy into making new cells when the fight or flight system is active. Instead, she reasons, that energy is needed to make a quick getaway. Peak moments of rest and digest may not be the best for making new cells, either, because when food is coming in, cellular processes related to digestion can create free radicals that can damage new cells." https://www.sciencedaily.com/releases/2018/10/181017141033.htm Quote Link to comment Share on other sites More sharing options...
firewatcher Posted October 17, 2018 Author Report Share Posted October 17, 2018 "Postural orthostatic tachycardia syndrome and neurocardiogenic syncope are clinical manifestations of autonomic nervous system dysfunction (dysautonomia) that can lead to impaired daily functions. We report two young patients presenting with dysautonomia and autoimmune disease who both received autologous adipose stem cells (ASCs) infusions. This report is the first description of ASCs therapy for patients with combined dysautonomia and autoimmune disease. Case 1: A 21-year-old female presented at 12 years of age with escalating severe dysautonomia with weight loss and gastrointestinal symptoms. She had elevated autoantibodies and cytokines and received multiple immune modulation therapies. Her dysautonomia was treated by volume expanders, vasoconstrictors, and beta blockers with mild improvement. She received ASCs about 2 years before this report with dramatic improvement in her dysautonomia and autoimmune symptoms with a 10 kg weight gain. Case 2: A 7-year-old boy presented at 2 years of age with polyarthritis. At 5 years of age, he manifested orthostatic intolerance. He received immune modulatory therapies with mild improvement. He received ASCs and showed marked improvement of his dysautonomia and immune symptoms. Dysautonomia symptoms of these two patients improved significantly after modulation of autoimmune components by ASC therapy. Favorable clinical responses of these two cases warrant further case–control studies." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346911/ Quote Link to comment Share on other sites More sharing options...
dancer65 Posted October 19, 2018 Report Share Posted October 19, 2018 Thank you for posting this very interesting to me Quote Link to comment Share on other sites More sharing options...
p8d Posted October 19, 2018 Report Share Posted October 19, 2018 Very interesting. Thanks for posting. I wonder if any larger clinical trials are being done with this therapy? Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.